Eliot M. Lurier
2022
In 2022, Eliot M. Lurier earned a total compensation of $221.7K as Interim Chief Financial Officer at Tenax Therapeutics, a 756% increase compared to previous year.
Compensation breakdown
| Other | $221,700 |
|---|---|
| Total | $221,700 |
Lurier received $221.7K in other compensation, accounting for 100% of the total pay in 2022.
Rankings
In 2022, Eliot M. Lurier's compensation ranked 5,338th out of 5,760 executives tracked by ExecPay. In other words, Lurier earned more than 7.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,338 out of 5,760 | 7th |
Division Manufacturing | 2,924 out of 3,136 | 7th |
Major group Chemicals And Allied Products | 1,355 out of 1,422 | 5th |
Industry group Drugs | 1,268 out of 1,323 | 4th |
Industry Pharmaceutical Preparations | 925 out of 969 | 5th |
Source: SEC filing on April 28, 2023.
Lurier's colleagues
We found two more compensation records of executives who worked with Eliot M. Lurier at Tenax Therapeutics in 2022.